Evidence map›Paper›PMID 37510136›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Prediction of Heart Disease Based on Machine Learning Using Jellyfish Optimization Algorithm.

Ahmad Ayid Ahmad, Huseyin Polat

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
29.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Ahmad Ayid AhmadComputer Engineering Department, Gazi University, Ankara 06560, Turkey.ORCID 0009-0008-1483-730X
Huseyin PolatComputer Engineering Department, Gazi University, Ankara 06560, Turkey.ORCID 0000-0003-4128-2625
Gazi University · TRUniversity of Kirkuk · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart disease is one of the most known and deadly diseases in the world, and many people lose their lives from this disease every year. Early detection of this disease is vital to save people's lives. Machine Learning (ML), an artificial intelligence technology, is one of the most convenient, fastest, and low-cost ways to detect disease. In this study, we aim to obtain an ML model that can predict heart disease with the highest possible performance using the Cleveland heart disease dataset. The features in the dataset used to train the model and the selection of the ML algorithm have a significant impact on the performance of the model. To avoid overfitting (due to the curse of dimensionality) due to the large number of features in the Cleveland dataset, the dataset was reduced to a lower dimensional subspace using the Jellyfish optimization algorithm. The Jellyfish algorithm has a high convergence speed and is flexible to find the best features. The models obtained by training the feature-selected dataset with different ML algorithms were tested, and their performances were compared. The highest performance was obtained for the SVM classifier model trained on the dataset with the Jellyfish algorithm, with Sensitivity, Specificity, Accuracy, and Area Under Curve of 98.56%, 98.37%, 98.47%, and 94.48%, respectively. The results show that the combination of the Jellyfish optimization algorithm and SVM classifier has the highest performance for use in heart disease prediction.

Indexed as

feature selectionheart disease diagnosisjellyfish optimizationmachine learningSVM

Identifiers

PMID37510136
PMCPMC10378171
OpenAlexW4384694684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.